PATENT CLAIM ANALYSIS

Application Number: 16198381
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "454000"]

Abstract:
This application is in the field of medicinal chemistry and relates to ultrapure ajulemic acid, its synthesis, pharmaceutical compositions and methods of use thereof for the treatment and/or prevention of inflammation, pain, and fibrotic diseases including scleroderma, systemic sclerosis, scleroderma-like disorders, sine scleroderma, liver cirrhosis, interstitial pulmonary fibrosis, idiopathic pulmonary fibrosis, Dupuytren's contracture, keloids, chronic kidney disease, chronic graft rejection, and other scarring-wound healing abnormalities, post-operative adhesions, and reactive fibrosis.

Claim (Index 40):
The method of  claim 36 , wherein said pharmaceutical composition is administered intravenously.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 98.0
- Lexical Diversity: 1.45902
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15347104', '15347059', '15698544', '15220127', '11003939']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8603508154227147
- 35 USC 102 Novelty (BERT): 0.5997518514460454
- Combined Prediction Score: 0.8342909190250478
- Mean Citation Score: 576.8707820000002
- Max Citation Score: 700.84607
- Similarity Product: 428.2506611331714

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test